Skip to main content
Gencurix Inc. logo

Gencurix Inc. — Investor Relations & Filings

Ticker · 229000 ISIN · KR7229000005 KO Manufacturing
Open in API
Filings indexed 405 across all filing types
Latest filing 2019-06-04 Director's Dealing
Country KR South Korea
Listing KO 229000

About Gencurix Inc.

https://www.gencurix.com/eng/

Gencurix Inc. is a molecular diagnostics company that develops and commercializes diagnostic solutions for precision medicine. The company's portfolio focuses primarily on oncology, offering prognostic, companion, and early detection tests. Key products include GenesWell BCT, a multigene prognostic test for early-stage breast cancer, and the GenesWell ddEGFR Mutation Test, a ddPCR-based companion diagnostic. Gencurix also utilizes its Droplex liquid biopsy platform for early cancer detection and develops diagnostic tests for infectious diseases. The company's core technologies include digital droplet PCR (ddPCR), real-time PCR, and liquid biopsy for analyzing circulating tumor cells (CTCs) and cell-free DNA (cfDNA).

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea (DART system) to report insider trading or changes in shareholdings by company directors and major shareholders. Based on the provided definitions, this corresponds to 'Director's Dealing' (DIRS).
2019-06-04 Korean
기타주요경영사항(자율공시)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from Gencurix regarding the withdrawal of their application for KOSDAQ market listing. It is a specific corporate announcement regarding a change in capital market strategy and listing status. Since it does not fit into specific categories like M&A, dividends, or share repurchases, and is a formal regulatory disclosure, it falls under the RNS (Regulatory Filings) category.
2019-05-28 Korean
기업설명회(IR)개최결과
Investor Presentation Classification · 98% confidence The document is a formal notification of the results of an Investor Relations (IR) meeting held by Gencurix. It lists the date, location, attendees, and agenda items of the meeting. Since it is a short regulatory announcement confirming that an IR event took place and where the materials can be found, it fits the definition of a Regulatory Filing (RNS) or a report publication announcement. Given the specific nature of the filing as a post-event disclosure to the Korea Exchange, RNS is the most appropriate classification.
2019-05-24 Korean
기업설명회(IR)개최
Investor Presentation Classification · 98% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2019-05-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically a decrease due to company split-off) by a major shareholder and their special related parties. This falls under the category of 'Major Shareholding Notification' (MRQ).
2019-04-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the shareholding status, changes in ownership, and the relationship between the reporting entity (Partners Investment) and the issuer (Gencurix). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2019-04-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.